According to a new report, published by KBV research, The Global Sustained Release Excipients Market size is expected to reach $1.9 billion by 2028, rising at a market growth of 8.4% CAGR during the forecast period.
The Transdermal market is poised to grow at a CAGR of 8.9% during (2022 - 2028). This method of administration reduces the number of drawbacks related to the parenteral and oral routes of administration. Transdermal patches are a simple way to promote the prolonged delivery of medications via the skin's surface. It is frequently chosen because it eliminates problems with the gastrointestinal system brought on by food interactions and enzymatic breakdown.
The Polymers market is leading the Global Sustained Release Excipients Market by Product in 2021; thereby, achieving a market value of $833.5 million by 2028. The usage of polymers in sustained-release formulations has significantly increased. For usage as an excipient in dry medicinal formulations, polymers have the ideal characteristics. Long molecules called polymers can be divided into smaller molecules. In addition to being composed of monomers, polymers also typically have a linear structure.
The Transdermal Technology market is expected to witness highest CAGR of 9.5% during (2022 - 2028). In comparison to conventional drug administration methods, transdermal sustained release technology provides a number of benefits, including the ability to circumvent hepatic first-pass metabolism, greatly reduce pharmacological side effects, and significantly increase patient compliance.
The Europe market dominated the Global Sustained Release Excipients Market by Region in 2021; thereby, achieving a market value of $670.9 million by 2028. The Asia Pacific market would witness a CAGR of 9% during (2022 - 2028). Additionally, The North America market is anticipated to grow at a CAGR of 7.8% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/sustained-release-excipients-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of BASF SE, International Flavors & Fragrances, Inc., Ashland Global Holdings Inc., Evonik Industries AG, Croda International Plc, Gattefossé, Merck Group, Pfizer, Inc., Novartis AG and AstraZeneca Plc.
By Route of Administration
By Product
By Technology
By Geography
Companies Profiled
Unique Offerings 
